China, Nov. 16 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Escitalopram Before Surgery and With Neoadjuvant Chemoimmunotherapy in Resectable Lung Squamous Cell Carcinoma'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600136698

Registration Time: 2026/11/13

Type: Interventional study

Primary Sponsor: Tianjin Medical University Cancer Institute and Hospital

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=349581

Published by HT Digital Content Services with permission from Health Daily Digest....